Bosentan for digital ulcers prevention does not worsen cardiopulmonary exercise test parameters in SSc patients with interstitial lung disease

Antonella Romaniello; Antonietta Gigante; Marcello Di Paolo; Gaia Tallerini; Biagio Barbano; Daria Amoroso; Paolo Palange; Edoardo Rosato

doi:10.1016/j.ijcard.2016.08.095

Bosentan for digital ulcers prevention does not worsen cardiopulmonary exercise test parameters in SSc patients with interstitial lung disease

Int J Cardiol. 2016 Nov 15:223:113-115. doi: 10.1016/j.ijcard.2016.08.095. Epub 2016 Aug 6.

Authors

Antonella Romaniello¹, Antonietta Gigante², Marcello Di Paolo³, Gaia Tallerini⁴, Biagio Barbano⁴, Daria Amoroso⁵, Paolo Palange³, Edoardo Rosato⁴

Affiliations

¹ Sapienza University of Rome, Department of Clinical and Molecular Medicine, Cardiology Unit, Italy.
² Sapienza University of Rome, Department of Clinical Medicine, Clinical Immunology Unit-Scleroderma Center, Italy. Electronic address: [email protected].
³ Sapienza University of Rome, Department of Public Health and Infectious Diseases, Italy.
⁴ Sapienza University of Rome, Department of Clinical Medicine, Clinical Immunology Unit-Scleroderma Center, Italy.
⁵ Sapienza University of Rome, Department of Emergency Medicine, Italy.

PMID: 27537734
DOI: 10.1016/j.ijcard.2016.08.095

No abstract available

Keywords: Cardiopulmonary exercise test; Endothelin receptor antagonists; Interstitial lung disease; Pulmonary arterial hypertension; Systemic sclerosis.

Publication types

Letter

MeSH terms

Adult
Bosentan
Disease Progression
Endothelin Receptor Antagonists / administration & dosage
Endothelin Receptor Antagonists / adverse effects
Exercise Test* / drug effects
Exercise Test* / methods
Female
Fingers*
Humans
Lung Diseases, Interstitial* / diagnosis
Lung Diseases, Interstitial* / etiology
Male
Middle Aged
Receptor, Endothelin A / metabolism
Respiratory Function Tests / methods
Scleroderma, Systemic* / complications
Scleroderma, Systemic* / drug therapy
Skin Ulcer* / etiology
Skin Ulcer* / prevention & control
Statistics as Topic
Sulfonamides* / administration & dosage
Sulfonamides* / adverse effects
Treatment Outcome

Substances

Endothelin Receptor Antagonists
Receptor, Endothelin A
Sulfonamides
Bosentan